Clinical implications of benzodiazepine pharmacokinetics
Am J Psychiatry. 1977 Jun;134(6):652-6.
doi: 10.1176/ajp.134.6.652.
Authors
R I Shader, D J Greenblatt
●
PMID:
17302
●
DOI:
10.1176/ajp.134.6.652
Abstract
Pharmacokinetic research has shown that clear differences exist among benzodiazepines in rate and route of elimination and in the presence or absence of pharmacologically active metabolites. These findings and other results of pharmacokinetic research have clinical implications in terms of dosage schedules, drug accumulation during long-term therapy, antianxiety therapy in the elderly, drug interactions, pharmacotherapy in specific disease states, and the influence of route of administration on drug action.
Publication types
●
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
●
Administration, Oral
●
Adult
●
Age Factors
●
Aged
●
Alcoholism / metabolism
●
Anti-Anxiety Agents / administration & dosage
●
Anti-Anxiety Agents / metabolism*
●
Chlordiazepoxide / metabolism
●
Clorazepate Dipotassium / metabolism
●
Diazepam / metabolism
●
Drug Interactions
●
Humans
●
Injections, Intramuscular
●
Injections, Intravenous
●
Intestinal Absorption
●
Liver / metabolism
●
Lorazepam / metabolism
●
Medazepam / metabolism
●
Oxazepam / metabolism
Substances
●
Anti-Anxiety Agents
●
Clorazepate Dipotassium
●
Oxazepam
●
Chlordiazepoxide
●
Lorazepam
●
Medazepam
●
Diazepam